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Riboswitches are RNA elements acting in cis, con-
trolling expression of their downstream genes
through a metabolite-induced alteration of their sec-
ondary structure. Here, we demonstrate that two
S-adenosylmethionine (SAM) riboswitches, SreA and
SreB, can also function in trans and act as noncoding
RNAs in Listeria monocytogenes. SreA and SreB
control expression of the virulence regulator PrfA
by binding to the 50-untranslated region of its
mRNA. Absence of the SAM riboswitches SreA and
SreB increases the level of PrfA and virulence gene
expression in L. monocytogenes. Thus, the impact
of the SAM riboswitches on PrfA expression high-
lights a link between bacterial virulence and nutrient
availability. Together, our results uncover an unex-
pected role for riboswitches and a distinct class of
regulatory noncoding RNAs in bacteria.
INTRODUCTION
Noncoding RNAs (ncRNAs) have been assigned a variety of
functions in both eubacteria and eukaryotes, where they gener-
ally act on distally encoded target mRNAs. In bacteria, ncRNAs
control multiple biological processes, including virulence
(Johansson and Cossart, 2003; Romby et al., 2006; Toledo-
Arana et al., 2007). They act either by sequestering target
proteins or by an antisense mechanism through base-pairing,
usually in the region of the ribosomal binding site of the target
mRNA (Guillier et al., 2006; Vogel and Wagner, 2007). Binding
of the ncRNA to the 50 untranslated region (50 UTR) region of
the mRNA often inhibits translation, and the corresponding770 Cell 139, 770–779, November 13, 2009 ª2009 Elsevier Inc.transcript is in most cases degraded. In recent years, ncRNAs
have been identified and characterized in many different path-
ogenic bacteria (Toledo-Arana et al., 2007). For instance,
RNAIII of Staphylococcus aureus has been shown to directly
control the fate of several mRNA targets involved in virulence
by RNA:RNA interactions (Boisset et al., 2007). In Listeria
monocytogenes, more than 40 ncRNAs have been identified,
with at least two being involved in virulence (Toledo-Arana
et al., 2009).
Expression of the virulence regulator PrfA of L. monocyto-
geneswas previously shown to be controlled by a thermosensor
located at the 50 UTR of the prfA transcript (Johansson et al.,
2002). At low temperatures (<30C), the 50 UTR of prfA forms
a secondary structure that masks the Shine-Dalgarno (SD) site
and prevents translation. At higher temperatures (37C), this
secondary hairpin structure is partially disrupted, enabling
binding of the ribosome and translation initiation.
It was recently discovered that certain 50 UTRs, termed
riboswitches, could control expression of their downstream
genes by directly binding a ligand, often being the end prod-
ucts in the metabolic pathway encoded by the downstream
genes (Nudler, 2006; Lu et al., 2008; Roth and Breaker,
2009). For example, by binding their effector molecule S-ad-
enosylmethionine (SAM), some SAM riboswitches form a termi-
nation structure that terminates transcription and inhibits
synthesis of the downstream mRNA (see Figure S1 available
online) (McDaniel et al., 2003; Winkler et al., 2003; Whitford
et al., 2009). In the absence of SAM, an antiterminator struc-
ture is instead formed and transcription proceeds. We have
tested whether terminated SAM riboswitches could function
as ncRNAs and control the expression of trans-encoded target
mRNAs via a direct interaction. We report here that two SAM
riboswitches in L. monocytogenes act as ncRNAs by interact-
ing with the 50 UTR of the mRNA encoding the master regu-
lator of virulence, PrfA.
Absence of a SAM Riboswitch Alters Expression
of trans-Encoded mRNAs
L. monocytogenes harbors seven putative SAM riboswitches
(also denoted as S-box or SAM-I) (Henkin, 2008; Roth and
Breaker, 2009) that were identified by tiling arrays and were
named Sre (SAM riboswitch element) (Toledo-Arana et al.,
2009) (Table S1). These potential riboswitch elements, desig-
nated SreA-G, are situated upstream of genes encoding proteins
involved in methionine and cysteine transport/metabolism and
have conserved regions (Figures S2 and S3). Several lines of
evidence indicate that these RNA elements constitute canonical
riboswitches that terminate transcription upon binding SAM:
(1) The core sequence regions of the seven RNA species show
a high degree of identity to SAM riboswitches acting at the tran-
scription level (Figure S3) (Winkler et al., 2003; Griffiths-
Jones et al., 2005). (2) One tested SAM riboswitch, SreA, was
transcribed together with its downstream genes (lmo2419-
lmo2418-lmo2417, encoding an ABC-transporter complex) at
stationary phase (low-nutrient conditions, Figure S4). At logarith-
mic growth phase (rich condition), SreAwas expressed as a short
terminated transcript (229 bases, Figure S4). (3) Addition of SAM
to an in vitro transcription assay caused an increased level of
termination in a degree similar to what was discovered for other
characterized SAM riboswitches (Figure S5) (Winkler et al.,
2003). On the basis of these observations, we consider SreA-G
to be canonical SAM riboswitches.
Because of their abundance and length, can terminated ribos-
witches function in trans, regulating distally located target
mRNAs/proteins? To study a possible trans-regulatory role of
riboswitch elements, we constructed a L. monocytogenes
wild-type strain (EGDe) lacking the longest and most expressed
riboswitch (SreA) (Table S1; Figures S1 and S6). The sreA dele-
tion mutant still carried the native promoter to ensure expression
of the downstream gene, lmo2419 (Figure S1). The mutant dis-
played the same growth rate as the wild-type strain and was
able to grow in minimal media (data not shown). To identify
genes putatively regulated by SAM riboswitch elements, we con-
ducted a transcriptome analysis experiment by comparing gene
expression of theDsreA strain and thewild-type strain. RNA from
the two strains, grown in rich conditions (brain heart infusion
[BHI]) when the termination product is synthesized, was isolated
from mid-logarithmic growth phase and subjected to whole
genome gene-array analysis (Table S2). Three genes showed
significant up-regulation, whereas six showed significant
down-regulation in the DsreA strain, compared to the wild-type
strain. Of these genes, two were chosen for further studies.
One, lmo2230, encodes a protein homologous to bacterial arse-
nate reductase and showed increased expression in the DsreA
strain. The other, lmo0049, encodes AgrD, which is the listerial
homolog of S. aureus autoinducing peptide (Riedel et al.,
2009). AgrD is important for biofilm formation and virulence in
L. monocytogenes and showed reduced expression in theDsreA
strain.
SreA Is Able to Function in trans Independently
of SAM Binding
In order to test the possible trans-regulatory function of SreA and
exclude effects caused by the downstream gene lmo2419, we
examined the effect of complementation on expression of
trans-regulated mRNAs. The DsreA strain was transformed
with psreAwt (i.e., the medium-copy number, replicative plasmid
pMK4 carrying the DNA fragment encoding the SreA riboswitch
[229 nucleotides], but not the downstream gene lmo2419;
Figure S1). In this construct, SreA is under the control of its native
promoter. The wild-type strain harboring pMK4, the DsreA strain
carrying pMK4, and the DsreA strain carrying psreAwt
were grown in BHI medium to mid-logarithmic growth phase
(OD600 =0.4).When expressedwith its native promoter in aDsreA
background, SreA could significantly restore expression of
lmo2230 and lmo0049 to a level similar to that detected in the
wild-type strain, as shown by northern blotting and by quantita-
tive reverse transcriptase-PCR (qRT-PCR) analysis (Figure 1).
On the basis of their sequence homology, it could be hypothe-
sized that other SAM riboswitches also could control expression
of lmo2230 and lmo0049. To test this, we inserted another SAM
riboswitch, SreB, into pMK4 carrying its native promoter and
Figure 1. SAM Riboswitch Elements Can Func-
tion in trans
Total RNA was isolated from the indicated strains
grown in BHI medium to a cell density of OD600 = 0.4.
(A) Northern blots (n = 3) were hybridized with
lmo2230-, lmo0049-, SreA-, SreB-, or tmRNA-specific
DNA probes. Specific products are indicated by
arrows. Sizes (bases) are indicated to the right of the
northern blots.
(B) Quantitative real-time-PCR (qRT-PCR) analysis
was performed using lmo2230-, lmo0049-, and
tmRNA-specific primers. Bars indicate the relative
expression of lmo2230 and lmo0049 in relation to
tmRNA (control) shown as mean values with standard
deviations (n = 5, except for DsreA+psreB, where
lmo2230 and lmo0049 measurements was repeated
4 and 2 times, respectively). All samples were
compared to DsreA + pMK4 using Student t test
(two-tailed) (*** p < 0.001; * p < 0.05).Cell 139, 770–779, November 13, 2009 ª2009 Elsevier Inc. 771
expressed in the DsreA strain. Expression of lmo2230 in that
strain was significantly restored to the level observed in the
wild-type strain carrying pMK4 and the DsreA strain carrying
psreAwt (Figure 1). In contrast, SreB was not able to restore
expression of lmo0049 to the levels observed in the DsreA strain
harboring psreAwt. This suggests that the trans-regulatory effect
of SreA on lmo2230 and lmo0049 expression is exerted by two
different mechanisms.
In order to investigate whether the binding of SAM to the ribos-
witch element is essential for the trans-effect observed, we con-
structed a riboswitch element unable to bind SAM and to form an
antitermination structure (Figure 2A). For such a construct, two
residues conserved in 1179 of 1182 known/predicted SAM
riboswitch elements in different species were altered in the
core of the metabolite-binding domain (GA/AG at position
61–62; Figure S3) (Winkler et al., 2003; Griffiths-Jones, et al.,
2005; Montange and Batey, 2006). Identical base substitutions
in a corresponding riboswitch element in Bacillus subtilis have
previously been shown to prevent SAM binding (Winkler et al.,
2003). To obtain the short transcript in the absence of SAM
binding, we also introduced base-substitution mutations dis-
rupting the formation of an antitermination structure in the
construct. The final construct was named psreANSB (non-SAM-
binding SreA). As predicted, a short transcript with a size iden-
tical to SreA was produced at logarithmic growth phase
(Figure 2A, right inset). In the DsreA strain harboring psreANSB,
the expression of lmo2230 was significantly restored to the level
observed in the wild-type strain supplemented with pMK4 or
DsreA supplemented with psreAwt, showing that SreA control
prfA expression independently of SAM binding (Figure 2B).
SreA Controls Expression of the Virulence
Regulator PrfA
Expression of lmo2230 has been shown to be activated by two
regulators, the sigma factor sB and the virulence regulator PrfA
(Milohanic et al., 2003). To investigate whether the increased
expression of lmo2230 in the DsreA strain was due to an altered
expression of these regulators, we isolated cytoplasmic protein
fractions and assessed expression of sB and PrfA by western
blotting. The levels of sB, as well as the expression of a known
sB-regulated gene (lmo0880), were similar in all strain back-
grounds (Figure S7; data not shown). In contrast, expression of
the PrfA protein increased approximately 2-fold in the strain
lacking SreA, compared to the wild-type strain (Figure 3A). In
the DsreA strain complemented with psreAwt, PrfA expression
was reduced to a level similar to or lower than that in the wild-
type strain. A similar effect of SreA on prfA expression could
be detected at the RNA level, although the prfA-transcript was
not reduced below wild-type levels in the DsreA supplemented
with psreAwt (Figure 3B). One of the virulence factors being
controlled by PrfA is hly, encoding Listeriolysin O, which is
essential for the bacterial escape from the phagosome. We
therefore tested whether a strain lacking SreA showed an altered
hly expression. TheDsreA strain showed an increased amount of
hly, compared with the wild-type strain (Figure 3B). The amount
of hlywas restored to wild-type levels in the DsreA strain supple-
mented with psreAwt (Figure 3B). To analyze whether SreA and
SreB function in concert to control expression prfA, we con-772 Cell 139, 770–779, November 13, 2009 ª2009 Elsevier Inc.structed a DsreA, DsreB double knockout mutant. The absence
of both SreA and SreB leads to a 3-fold increased expression of
prfA, compared to the wild-type strain (Figure 3C). This indicates
that both SreA and SreB act together to control expression of
prfA.
Expression of SreA Is Controlled by PrfA
When searching for PrfA consensus binding sites in the promoter
region of SreA and SreB, we identified putative PrfA binding sites
upstream of SreA and SreB (Figure 4A). This prompted us to
investigate whether the expression of SreA and SreB was
Figure 2. The trans Function of SreA Is Independent of SAM Binding
(A) Sequence and structural model of the SreA riboswitch in two structural
states. Sequences boxed in green indicate base-substitution mutations intro-
duced to eliminate SAM binding (Winkler et al., 2003). Sequences boxed in red
indicate base-substitution mutations introduced to prevent formation of an
antitermination structure. Structure model of wild-type SreA in the presence
of SAM (large picture) or in the absence of SAM (left inset). Northern blot anal-
ysis of SreA expression in the DsreA + psreAwt and the DsreA + psreANSB
strains grown to OD600 = 0.4 (right inset). Membrane was hybridized with
SreA-specific 32P-labeled PCR amplified fragments. The SreA transcript is
shown by an arrow.
(B) Analysis of lmo2230 and tmRNA expression. Total RNA was isolated from
indicated strains grown in BHI medium to a cell density of OD600 = 0.4.
Northern blots (n = 3) were hybridized with lmo2230 or tmRNA-specific
32P-labeled PCR amplified fragments. Specific products are indicated by
arrows. For qRT-PCR analysis (n = 3), either 5 ng (lmo2230) or 250 pg (tmRNA)
of each RNA sample was used with lmo2230 and tmRNA specific primers.
Bars indicate the relative expression of lmo2230 in relation to tmRNA (control)
as the means with standard deviations. All samples were compared toDsreA +
pMK4 using Student t test (two-tailed) and showed a significant difference
against DsreA+pMK4 (* p < 0.05).
controlled by PrfA. As demonstrated in Figure 4A, a reduction in
the expression of both SreA and SreB was observed in a DprfA
knockout strain. We and others have previously shown that
expression of PrfA- and PrfA-regulated genes was increased
after bacterial adhesion to and entry into host cells (Renzoni
et al., 1999; Moors, et al., 1999; Scortti et al., 2007). It was there-
Figure 3. Expression of PrfA Is Increased in the Absence of SreA
(A) Western blot analysis of the expression levels of PrfA. Total protein was
isolated from the indicated strains and was subjected to western blot analysis
(n = 2). Membranes were probed with antibodies recognizing PrfA or GroEL
(control).
(B) Northern blot analysis of prfA and hly expression. Total RNA was isolated
from the indicated strains grown in BHI medium to a cell density of OD600 =
0.4 and was subjected to northern blot analysis (n = 3). Membranes were
hybridized with prfA-, hly-, and tmRNA-specific DNA probes. Specific prod-
ucts are indicated by arrows.
(C) Northern blot analysis of prfA expression. Total RNAwas isolated from indi-
cated strains grown in BHI medium to cell density of OD600 = 0.4 and was sub-
jected to northern blot analysis (n = 2). Membranes were hybridized with prfA
and tmRNA probes. Specific products are indicated by arrows. Below is
shown a quantification of the prfA bands on northern using STORM repre-
sented as mean with standard deviations. Expression of prfA is correlated to
tmRNA.fore of interest to test whether SreA was induced intracellularly,
thus giving support for a PrfA-mediated regulation. In agreement
with this hypothesis, we found that the level of SreA was
increased 7-fold after the bacteria had invaded HeLa cells
(Figure 4B).
SreA and the prfA-UTR Interact in Escherichia coli
Analyzing the sequences of SreA and the 50 UTR region of prfA
revealed a high degree of complementarity between the paired
region 3 of SreA and the distal side of the prfA-UTR stem
(Figure 5A). When the SreA:prfA-UTR interaction was analyzed
with the RNAhybrid program (Rehmsmeier, et al., 2004), a DG
value of 38.1 kcal/mol was calculated. To test whether SreA
and prfA directly interact without involvement of any other
listerial factor(s), we used an ectopic system in Escherichia
coli, which does not harbor any SAM-I riboswitches or prfA.
A plasmid expressing a prfA-gfp fusion (Johansson et al., 2002)
was introduced into E. coli, together with pMK4 or psreAwt.
A similar GFP expression approach has previously been used
to verify ncRNA-mRNA interactions (Urban and Vogel, 2007).
Figure 4. The SreA Riboswitch Is Controlled by PrfA and Is Induced
Intracellularly
(A) Northern blot analysis of SreA expression. Total RNA was isolated from the
wild-type (WT) and the DprfA strain grown in BHI medium to a cell density of
OD600 = 1.2 and was subjected to northern blot analysis (n = 2). Membranes
were hybridized with SreA-, SreB-, or tmRNA-specific DNA probes. Specific
products are indicated by arrows. Suggested PrfA-binding sites lying in front
of the SreA and SreB promoters are shown together with the consensus
PrfA-binding site. Bases corresponding to the PrfA-binding consensus are
shown in red.
(B) Intracellular expression of SreA. Wild-type L. monocytogenes was allowed
to infect HeLa cells for 4 hr before bacteria and total RNA were isolated. As
a control, L. monocytogenes was grown in cell-culture medium without
HeLa cells before RNAwas isolated (n = 3). The amount of SreA for both extra-
cellularly and intracellularly grown bacteria was quantified using qRT-PCR,
related to tmRNA and represented as mean with standard deviations.Cell 139, 770–779, November 13, 2009 ª2009 Elsevier Inc. 773
GFP expression was examined by measuring fluorescence of
bacteria directly on agar plates or by western blot detection
of PrfA-GFP from bacteria grown in liquid culture to an OD600
of 0.4. If SreA and prfA directly interact, the presence of SreA
should decrease expression of PrfA-GFP. In line with this
hypothesis, the presence of SreAwt dramatically reduced fluo-
rescence of plated bacteria (Figure 5B). In addition, expressing
prfA-gfp together with the non-SAM-binding SreA (SreANSB)
completely repressed GFP expression in a degree similar to
SreAwt, thus further proving that the trans-regulatory mechanism
of SreA is independent of SAM binding (Figure 5B). When
bacteria were grown in liquid culture, the presence of SreAwt
lowered the level of PrfAwt-GFP dramatically, compared with
that of the vector control (Figure 5C). The effect of SreA on
prfA expression appears to be more pronounced in E. coli than
in L. monocytogenes, possibly because no other SAM-I ribos-
witches are present in E. coli.
Mutations Weakening the Putative SreA:prfA-UTR
Interaction Increase PrfA Expression
By analyzing the putative SreA:prfA-UTR interaction site, a more
GC-rich region was detected at the base of the stem (Figure 5A).
Several base substitutions that increased the theoretical DG
value (from 38.1 to approximately 27 kcal/mol) were intro-
duced into either SreA (M1) or prfA (M1*) (Figure 5A). If SreAwt
and prfAwt directly interact, such base substitutions should
weaken the repressive effect by SreA on PrfA-GFP expression.
Indeed, repression by SreA was nearly abolished when SreAM1
was expressed in the presence of prfAwt-gfp as determined by
analyzing protein levels from bacteria grown in liquid culture
(Figure 5C).
Making the reciprocal experiment was not possible: Base
substitutions in the prfA-UTR (M1*) that destabilize a putative
SreA:prfA interaction also disrupt base pairing in the bottom
part of the prfA-thermosensor (Figure 5A) (Johansson et al.,
2002). Because the SD region of the prfA-thermosensor is
open at 37C, the M1* mutation creates a prfA thermosensor
with an open base and, hence, an extensively deregulated PrfA
expression at that temperature (Figure S8). This situation made
it impossible to study the effect of SreAwt and SreAM1 on
prfAM1)-gfp expression in vivo (data not shown). We thus
analyzed the SreA:prfAM1) interaction in vitro (see below).
To investigate further the action of SreA, we examined expres-
sion ofprfA-gfp andSreA transcripts and found it to correlatewith
the observed protein expression pattern, although the level of
theseRNAspeciesdidnot vary asextensively as theprotein levels
(Figure S9). These results suggest that SreA, by a direct interac-
tion, regulates PrfA expression mainly at the translational level.
Figure 5. SreA Interacts with the prfA-UTR
in Escherichia coli
(A) Predicted secondary structures of the prfA-
UTR and SreA together with a putative interaction
site as indicated by the RNAhybrid program
(Rehmsmeier et al., 2004). Paired regions in SreA
are labeled P1 to P4 and the terminator T. The
SD site and start codon of prfA are indicated by
purple and green boxes, respectively. The sug-
gested bases interacting between SreA and
prfA-UTR are indicated by red letters in SreA and
by blue letters in the prfA-UTR. Base substitution
mutation constructs (M1 and M1*) are indicated
in black boxes.
(B) Fluorescence measurements on agar plate.
The indicated strains were streaked on LA agar-
plate and grown at 37C for 24 hr (n = 2). Fluores-
cence was measured with an IVIS-spectrum
imaging system. Color scale represents level of
fluorescence intensity ranging from high (yellow)
to low (dark red).
(C) Western blotting evaluating the amount of
PrfA-GFP. The indicated strains were grown to
an OD600 of 0.4 at 37
C. Total protein was isolated
from the indicated strains and subjected to
western blot analysis (n = 5). Membranes were
probed with antibodies recognizing GFP or GroEL
(control).
(D) Expression of SreB inhibits PrfA-GFP expres-
sion. The indicated strains were grown to an
OD600 = 0.4. Total protein was isolated and was
subjected to western blot analysis (n = 3).
Membranes were probed with antibodies recog-
nizing GFP or GroEL (control).
(E) Temperature-dependent SreA repression of
PrfA-GFP expression. The indicated strains were grown to an OD600 of 0.4 at either 30
C or 37C. Total protein was isolated from the indicated strains and sub-
jected to western blot analysis (n = 3). Membranes were probed with antibodies recognizing GFP or GroEL (control).774 Cell 139, 770–779, November 13, 2009 ª2009 Elsevier Inc.
Could SreB also control PrfA expression in E. coli? To answer
this question, we expressed SreB together with prfA-gfp in
E. coli. The results indicate that SreB indeed could repress
expression of PrfA-GFP in a manner similar to SreA, suggesting
that SreB and prfA directly interact (Figure 5D).
SreA Is Unable to Interact with the prfAwt-UTR
at Low Temperatures
We have previously shown that expression of PrfA is low at
temperatures below 30C as the result of an RNA thermosensor
within the 50 UTR (Johansson et al., 2002). To test whether the
repressive effect of SreA on PrfA expression was also detected
at low temperatures, we grew strains carrying prfAwt-gfp with
either pMK4 or psreAwt at 30
C or 37C. As seen in Figure 5E,
SreAwas not able to repress PrfA expression at 30C, in contrast
to 37C. This is probably due to an inability of SreA to interact
with the closed conformation of the prfA thermosensor at 30C
(Johansson et al., 2002). Opening of the thermosensor at 37C
not only allows ribosomal binding, but also permits a possible
repressive interaction with SreA.
SreA and the prfA-UTR Interact Directly In Vitro
To further validate the SreA:prfA-UTR interaction and exclude
indirect effects, we synthesized full-length SreA and prfA-UTR
RNA in vitro, and their putative interaction was studied by native
gel shift assay. The addition of SreAwt caused the prfAwt-UTR
fragment to shift (Figure 6A). Such a shift was almost not de-
tected when SreAwt was added to prfAM1)-UTR. In contrast,
when SreAM1 was added to the prfAM1)-UTR fragment, the shift
was as strong as that observed for the SreAwt:prfAwt-interaction.
These results show that SreA and prfA-UTR directly interact and
that the M1:M1* region is essential for such a contact. SAM does
Figure 6. SreA and prfA Interact In Vitro
(A) Gel shift experiments with SreA and radioactively labeled prfA-UTR. Indi-
cated RNA fragments (prfAwt, prfAM1), SreAwt, or SreAM1) were incubated
simultaneously at 37C for 30 min before separation on native polyacrylamide
gels (n = 3). Free prfA or prfA in complex with SreA is indicated by arrows.
(B) SreA inhibits PrfA-GFP expression in an in vitro transcription/translation
assay. The prfA-gfp plasmid was incubated in the presence or absence of
3 mg SreA or 3 mg VrrA before samples were taken for western blotting (n = 3).not seem to be important for the trans-acting function of SreA
(Figures 2 and 5B), but it could be hypothesized that SAM affects
the SreA:prfA-UTR interaction. To test this, we performed native
gel shift experiments with SreAwt and the prfAwt-UTR fragment in
the presence and absence of SAM. Addition of SAM did not
affect the interaction between SreA and the prfA-UTR, clearly
indicating that SAM is not essential for the SreA:prfA interaction
(Figure S10).
For additional corroboration of the interaction between SreA
and prfA-UTR, an in vitro transcription/translation approach
was undertaken, with prfAwt-gfp expressed from a plasmid in
the presence or absence of SreA RNA. The recently identified
ncRNA, VrrA, from Vibrio cholerae (Song et al., 2008), was
included as a control. Expression of PrfA-GFP was reduced
70%–80% by the addition of SreA, but was unaltered by the
addition of VrrA (Figure 6B).
Altogether, our in vivo and in vitro results suggest an ncRNA
function for SreA, by which it binds to the 50 UTR of prfA and
thereby reduces prfA transcript stability and/or prfA mRNA
translation.
DISCUSSION
In this paper, we describe for the first time, to our knowledge,
that a riboswitch known to control transcription of its down-
stream gene (cis-function) also functions as a small noncoding
RNA and regulates expression of distally located target mRNAs
(trans-function). More specifically, we show that the S-adenosyl-
methionine riboswitch SreA binds to the distal side of the prfA-
untranslated RNA, thereby causing decreased expression of
PrfA. Several lines of evidence suggest that the interaction
between SreA and the prfA-UTR is direct: First, SreA shows
a high degree of complementarity between paired region 3 and
the distal side of the prfA-UTR by in silico analysis (Figure 5A).
Second, expression of prfA-gfp in the ectopic E. coli system is
decreased approximately 10 fold in the presence of SreA,
compared to the vector control (Figures 5B and C). Third,
base-substitutionmutations in SreA or in the prfA-UTR predicted
to destabilize the prfA:SreA interaction abolish SreA-mediated
repression (Figure 5C; data not shown). Fourth, SreA and the
prfA-UTR interact directly in vitro requiring the M1:M1* regions,
as determined by RNA:RNA gel-shift assay (Figure 6A). Fifth,
SreA inhibits synthesis of PrfA-GFP in an in vitro transcription/
translation assay (Figure 6B). These two last points exclude
effects by other cellular factors (Figures 6A and 6B). Importantly,
the interaction between SreA and prfA is independent of SAM
binding (Figures 2, 5B, and S10). Although SAM is not required
for prfA and SreA to interact, it does not rule out the possibility
that SAM is part of the prfA:SreA complex.
Interactions between ncRNAs and specificmRNA targets have
previously been reported in variousbacterial species, includingL.
monocytogenes (Majdalani et al., 1998; Altuvia et al., 1998; Lenz
et al., 2004; Morita et al., 2006; Boisset et al., 2007; Mandin et al.,
2007; Sharma et al., 2007; Darfeuille et al., 2007; Urban and
Vogel, 2007; Song et al., 2008). On the basis of our findings,
we propose that riboswitches can also function as noncoding
RNAs. Base-substitutions mutations tested in vivo and
in vitro suggest that the SreA:prfA-UTR interaction-site residesCell 139, 770–779, November 13, 2009 ª2009 Elsevier Inc. 775
approximately 80 bases upstreamof theSDsite ofprfA (Figures 5
and 6). This would represent an interaction area unusually distant
from the SD site, a situation that has only been reported for a few
ncRNAs (Sharma et al., 2007; Darfeuille et al., 2007). In order to
understand more precisely the mechanism by which SreA
represses prfA expression, it will be important to determine
exactly the SreA:prfA-UTR interaction area, work that is now in
progress.
Another SAM riboswitch, SreB, was also able to bind to and
control expression of prfA and, hence, also lmo2230 (Figures
1, 3C, 5D, and S11). Interestingly, SreB was not able to control
expression of lmo0049, suggesting that unique parts of SreA
absent in SreB control lmo0049 expression. We do not know
whether other SAM riboswitches can bind to and control expres-
sion of prfA, although such interactions could be suggested by
computer predictions albeit with different strength (Figure S11).
In addition, the intracellular stability of the different SAM ribos-
witches varies dramatically (Table S1).
The absence of SreA increases the amount of PrfA but
decreases the amount of lmo0049, the latter encoding a
quorum-sensing molecule, AgrD, that is important for invasion
of intestinal epithelial Caco2-cells (Riedel et al., 2009). Expres-
sion of lmo0049 was not controlled by PrfA (Toledo-Arana
et al., 2009). Interestingly, expression of prfA was much higher
in bacteria exposed to blood, compared to intestinally grown
bacteria (Figure S6) (Toledo-Arana et al., 2009). In contrast,
lmo0049 is more expressed in the intestine than in the blood,
suggesting that AgrD is more important than PrfA as a regulatory
component in the intestine. In agreement with this hypothesis,
PrfA has recently been shown to be less critical for expression
of virulence genes in the intestine (Toledo-Arana et al., 2009).
We do not know the impact of SreA on virulence, but its opposite
function for expression of two important virulence activators
(AgrD and PrfA) suggest it to be central. We have measured
the absolute number of SreA in the bacterium. Our results
suggest that only seven copies of SreA/bacterium are present
when the bacteria are grown in BHI medium to an OD600 of 0.4
(Table S1). SreA is more abundant during L. monocytogenes
exposure to blood and intestinal infection, compared with
growth in BHI medium, with its total number increasing to 20–
40 molecules/bacterium (Table S1; Figure S11) (Toledo-Arana
et al., 2009). prfA and SreA are equally abundant when bacteria
are exposed to blood (Figure S6). In contrast, the amount of prfA
is much lower during growth in the intestine (less than one copy/
bacteria). Clearly, the physiological roles of SreA and SreB
remain to be precised, but our work suggest a role for them (as
well as other listerial SAM-I riboswitches) to down-regulate
PrfA-expression in compartments (i.e., intestine) where other
regulatory pathways are active (i.e., AgrD).
PrfA expression is controlled at several levels: transcriptional,
translational, and posttranslational (Scortti et al., 2007). As we
have previously shown, expression of PrfA is inhibited during
growth at low temperatures because of an RNA thermosensor
within the 50 UTR (Johansson et al., 2002). Interestingly, SreA
is not able to interact with the thermosensor at low temperatures
when the latter is present in the most stable conformation
(Figure 5E) (Johansson et al., 2002). This implies a function of
SreA on PrfA expression only at temperatures permissive for776 Cell 139, 770–779, November 13, 2009 ª2009 Elsevier Inc.infection (i.e., 37C) and not at lower temperatures. Another layer
of complexity is that SreA expression is PrfA dependent, thereby
forming a regulatory loop where a high level of PrfA activates
transcription of SreA, which, in turn, down-regulates PrfA
expression (Figures 3 and 4).
Finally, our data do not rule out a regulatory role for the SAM
riboswitches when they are part of a longer, antiterminated, tran-
script. We anticipate that other classes of riboswitch elements,
controlling their downstream genes by a transcription termina-
tion mechanism, might also be able to function as ncRNAs in
a manner similar to SreA.
EXPERIMENTAL PROCEDURES
Oligonucleotides, Strains, Plasmids, Growth Media,
and Culture Conditions
The oligonucleotides used in this study are listed in Table S3. The strains and
plasmids used in this study are listed in Table S4. L. monocytogenes strains
were grown in BHI broth or agar (Fluka), and E. coli Novablue (Novagen) was
grown in Luria-Bertani (LB) broth and agar. For RNA isolation, L. monocyto-
genes overnight cultures were diluted 100-fold and grown to the indicated
optical density (0.4) in the absence of antibiotics. For knockout constructions
and overnight cultures, antibiotics were added at the following concentrations:
carbenicillin, 100 mg/ml1; chloramphenicol, 7 mg/ml1; and erythromycin,
7 mg/ml1. All strains were grown at 37C with aeration. The human-derived
epithelial cell line HeLa was cultured in RPMI 1640 medium supplemented
with 10% FBS and 5 mM glutamine. The cell line was maintained at 37C in
a 5% CO2-air atmosphere.
Site-Directed Mutagenesis
In order to obtain site-specific mutations in SreA, we used the Quikchange
site-directed mutagenesis kit from Stratagene. Plasmid pMK4 harboring the
sreA fragment was used as template in the mutagenesis reactions. To achieve
a SreA construct unable to bind SAM, oligonucleotides #47basesub1-U and
#47basesub1-L were used (Table S3). The resulting construct was sequenced,
and the correct plasmid was used as template together with the oligonucleo-
tides #47basesub2-U and #47basesub2-L (Table S3) to create a SreA
construct unable to form an antitermination structure. The resulting plasmid
(psreANSB) was sequenced, to ensure that no other changes had occurred.
To achieve a SreA construct lacking the putative M1 site (SreAM1), oligonucle-
otides SreAM1-U and SreAM1-Uwere used (Table S3). The resulting construct
was sequenced. SreAM1 could not be created unless the10 region preceding
SreAwasmutated from TAATAT to TAGTAT, thereby lowering the total amount
of SreA (data not shown). This base-pair replacement was also introduced into
the SreAwt construct. The prfAM1)-GFP was made as follows: Plasmid pEGFP-
prfA (Johansson et al., 2002) was used as a template with the oligonucleotides
PrfAM1*-U and PrfAM1*-L (Table S3). The resulting plasmid was sequenced,
to ensure that no other changes had occurred.
Statistical Analysis
Statistical analysis was performed by using Student t test (two-tailed distribu-
tion, two-sample equal variance) when indicated in the figure legends.
RNA Isolation
Total cellular RNA was isolated from L. monocytogenes by dissolving pelleted
cultures (20 ml, A600 = 0.4) in resuspension solution (10% glucose, 12.5 mM
Tris [pH 7.6], and 5 mM EDTA) and fresh EDTA (0.5 M). Samples were imme-
diately transferred to bead beater tubes with roughly 0.4 g glass beads and
500 ml of acid phenol (pH 4.5). The bacteria were disrupted using a mini
bead beater (Biospec products) for 75 s. After centrifugation (5 min,
20 8003 g) RNAwas recovered by addition of 1ml of trizol and 100 ml of chloro-
form/isoamylalcohol (24:1), followed by centrifugation. Samples were there-
after subjected to two additional chloroform/IAA extractions. The aqueous
phase was precipitated by adding isopropanol (0.73) and incubated at
20C for 20 min. For collection of the pellet, the RNA samples were centri-
fuged for 25 min. The pellet was dissolved in 200 ml of RNase-free water.
For removal of the remaining DNA, samples were treated with 20 U of
DNase_ (Ambion) for 45 min at 37C. The reaction was terminated by addition
of phenol/chloroform/IAA (1:24:1 [pH 6.6]). Centrifuged samples were chloro-
form/IAA extracted and ethanol precipitated. The pellet was resuspended in
200 ml RNase-free water, RNA concentration was measured on a Nanodrop
(Nanodrop ND-1000 Spectrophotometer), and the RNA integrity was deter-
mined on a 1.2% agarose gel. Only RNA samples showing distinct nonpro-
cessed precursors to ribosomal RNA were used in the following experiments.
Northern Blot
For northern blotting, 20 mg of total RNA was separated on a formaldehyde
agarose gel prior to blotting as described (Toledo-Arana et al., 2009). The Hy-
bond-N membrane was subsequently hybridized with 32P a-labeled DNA frag-
ments amplified with corresponding primers. Northern blots were developed,
and band intensities were measured in the STORM machine (Molecular
Dynamics). Primers used are listed in Table S3. To amplify a DNA fragment
for detection of lmo2230, lmo0049, SreA, SreB prfA, gfp, hly, lmo2419, and
tmRNA, we used primers lmo2230-U and lmo2230-L, lmo0049-U and
lmo0049-L, sreA-U and sreA-L, sreB-U and sreB-L, prfA-U and prfA-L, prfA-U
and gfp-L, hly-U and hly-D, lmo2419-U and lmo2419-L, and tmRNA-U and
tmRNA-L, respectively.
RNA Stability
Indicated L. monocytogenes strains were grown at 37C in a shaking water
bath, until A600 = 0.4. Initiation of transcription was stopped by the addition
of rifampicin to 250 mg/ml, and samples were collected at indicated time points
for RNA isolation and qRT-PCR.
Real-Time Quantitative PCR with Reverse Transcriptase
Real-time PCR quantification of RNA templates was conducted with a Biorad
iCyclerIQ according to the manufacturer’s description. In brief, an iScript one-
step RT-PCR kit with SYBR GREEN (BioRad) was used with 5 ng (lmo2230,
lmo0049, SreA, SreB, SreC, SreD, SreE, SreF, SreG, and prfA) or 250 pg
(tmRNA) total RNA template in a total volume of 25 ml. Primers used are listed
in Table S3. Cycles were as follows: 50C for 10 min, 95C for 5 min, (95C for
10 s and 55C for 30 s) 45 times. qRT-PCR data in Figures 1 and 2 were
compared to DsreA plus pMK4 using Student t test (two-tailed; *** p < 0.001,
* p < 0.05).
Determination of SreA Molecules/Bacterium
qRT-PCR was performed with different dilutions of purified SreA transcript
used as a standard curve and total RNA from cultures isolated at OD600 =
0.4. By this, the total mass of SreA/ml culture could be determined. By knowing
the number of bacteria/ml culture, the molecular mass of SreA and the Avoga-
dro constant, the number of SreA/bacterium could be measured (7 ± 3).
SDS-PAGE and Western Blotting
The different cultures were grown in BHI (L. monocytogenes) or LB medium (E.
coli) to an optical density of OD600 = 0.4. Bacteria were centrifuged and resus-
pended in buffer A (200 mM KCl, 50 mM Tris-HCl [pH = 8.0], 1 mM EDTA, and
10% glycerol). The suspension was disrupted using a bead-beater for 1.5 min
at maximum speed. After 2 min on ice, the suspension was centrifuged at
15,000 rpm for 5min, and the supernatant (cytoplasmic fraction) was removed.
Protein samples were separated on a 12% polyacrylamide gel electrophoresis
before being transferred onto a PVDF membrane using a semidry blotting
apparatus. Development of the membrane essentially followed the protocol
of the ECL+ western blotting kit (Amersham), using anti-PrfA (IS3b - R78),
anti-sB, anti-GFP (BD-living colors), or anti-GroEL as primary antibodies and
HRP-conjugated anti-rabbit or anti-goat as secondary antibodies (Bio-Rad).
Measurement of protein expression was carried out in the STORM machine
(Molecular Dynamics).
In Vitro Transcription Termination Experiments
PCR was used to generate DNA templates containing either T7 promoter or
native promoter in front of the SreA riboswitch element using primers 47-Ror sreApT7U together with lmo2419-L (Table S3). One microgram of PCR
product was used as template. Reactions were performed in a volume of
30 ml and contained for the T7 polymerase reactions 0.2 mM ATP, GTP,
CTP, 5 mCi a-32 P UTP, and 50 U T7 RNA polymerase, and for the RNA holo-
enzyme reactions 0.25mMATP, GTP, CTP, 5 mCi a-32 P UTP, and 2.5 U E. coli
RNA Polymerase Holoenzyme (Epicenter Biotechnologies). Both T7 poly-
merase and RNA holoenzyme reactions were incubated in the presence of
40 mM Tris-HCl, 6 mM MgCl2, 2 mM spermidine, 10 mM dithiothreitol
(pH 7.9 at 25C), and 40 U Ribolock TM RNase inhibitor (Fermentas) for 2 hr
at 37C. SAM was added at a concentration of 50 mM. Reactions were dena-
tured in the presence of formamide dye mix and were separated by 8% urea-
PAGE. Gels were dried and visualized by PhosphorImager.
RNA-RNA Gel Shift
RNA gel shift assays were performed as described earlier (Mandin et al., 2007).
In brief, uniformly 32P-UTP-labeled prfAwt and prfAM1) were synthesized
in vitro using T7 RNA polymerase and PCR fragments as template, before puri-
fication of the RNA fragments on Urea-PAGE gel. The PCR fragments were
amplified with prfA-pT7 and prfA-5 oligonucleotides and pprfAwt-gfp or
pprfAM1)-gfp as template (Table S3). ‘‘Cold’’ SreAwt and SreAM1 were synthe-
sized in vitro using T7 RNA polymerase and PCR fragments as template. The
PCR fragments were amplified with SreA-pT7U and SreA-T7U oligonucleo-
tides and psreAwt and psreAM1 as template (Table S3). Complex formation
assays were performed at 37C for 30 min in a buffer containing 20 mM
Tris-HCl (pH 7.5), 10 mM MgCl2, and 150 mM NaCl in the presence of
600 nM of each RNA-fragment. When indicated, 50 mM of SAM was added
to the reactions 15 min after complex formation initiation incubation.
In Vitro Transcription/Translation
Three micrograms of in vitro transcribed SreAwt or VrrA (PCR synthesized
using oligos T7 and VrrA-D) was incubated together with 0.3 mg of
pT7pprfAwt-gfp plasmid (T7 driven prfA-gfp, amplified using primers prfA-
pT7 and gfpD with pprfAwt-gfp as template and inserted into pGEM-T) in an
S30 T7 high yield in vitro Transcription/Translation Kit (Promega) according
to the manufacturer’s instructions. In brief, the mixtures were incubated at
25C for 5 min before transfer to 37C for an additional 5 min. Samples were
acetone-precipitated, resuspended in sample buffer, and separated on
a 12% polyacrylamide gel electrophoresis, before being transferred onto
a PVDF membrane using a wet blotting apparatus (Biorad). Development of
the membrane essentially followed the protocol of the ECL+ western blotting
kit (Amersham), using anti-GFP (BD-living colors) as primary antibodies and
HRP-conjugated anti-goat as secondary antibodies (Bio-Rad).
Fluorescent Imaging on Agar Plate
Bacterial strains were streaked onto a LB-plate containing carbenicillin
(100 mg/ml) and kanamycin (50 mg/ml) and were grown overnight. Fluores-
cence imaging was performed with an IVIS Spectrum imaging system
(Xenogen). A GFP filter (excitation wavelength 445–490 nm and emission
515–575 nm) was used for acquiring fluorescence imaging. Identical illumina-
tion settings, such as exposure time (1 s) and field of views (153 15 cm), were
used for acquiring all images. Fluorescence emission was normalized to
photons per second per centimeter squared per steradian (p s-1 cm-2 sr-1).
Images were acquired and analyzed using Living Image 3.0 software
(Xenogen).
cDNA Labeling and Hybridization
Chromosomal DNA (30 ng) isolated from L. monocytogenes strains EGDe or
DsreA was 33P-labeled using a random primed DNA labeling kit (Boehringer
Manheim). Labeled genomic DNAs were purified prior to hybridization using
QIAquick columns (QIAGEN). For cDNA synthesis, random hexamers primers
were used in reverse transcription reactions in the presence of [a-33P]dCTP
(2000–3000 Ci mmol1, Amersham). One microgram of total RNA and 50 U
AMV reverse transcriptase (Roche) with Rnase H activity were used. Labeled
cDNA was purified prior to hybridization using a QIAquick column (QIAGEN).
Hybridization and washing steps were carried out using SSPE buffer (0.18 M
NaCl, 10 mM NaH2PO4, and 1 mM EDTA [pH 7.7]). Macroarrays were pre-wet
in 23 SSC and prehybridized for at least 2 hr in hybridization solutionCell 139, 770–779, November 13, 2009 ª2009 Elsevier Inc. 777
(53 SSPE, 2% SDS, 13 Denhardt’s reagent, and 100 mg of sheared salmon
sperm DNA/ml1) at 65C in roller bottles. Hybridization was carried out for
20 hr at 65C in hybridization solution and the entire spin-purified cDNA probe.
For each strain, two independent RNA preparations were tested, and two
cDNAs from each of the RNA preparations were hybridized to two sets of
arrays and analyzed.
Membranes were scanned using a 445SI phosphorImager (Molecular
Dynamics). The ArrayVision software (Imaging Research, St Catherines, ON,
Canada) was used for quantification of the hybridization intensities and for
normalization. For identification of genes with statistically significant changes
in expression SAM (Significance Analysis of Microarrays, http://www-stat.
stanford.edu/tibs/SAM/) was used. Genes whose expression change was
2-fold in all arrays and significant according to this analysis were taken into
account (Table S2). All gene-array data have been deposited at ArrayExpress
with the accession number E-MTAB-118.
Cell Culture, Infection, and Isolation of RNA
Wild-type L. monocytogenes was grown in 100 mm diameter tissue culture
plates with and without HeLa cells. For extracellular experiments, Listeria
was allowed to grow for 4 hr in supplemented RPMI 1640 medium. For intra-
cellular experiments, Listeriawas allowed to infect the cells. After 1 hr of infec-
tion, the plate containing HeLa cells and L. monocytogenes was washed with
fresh supplemented RPMI 1640 medium twice, and a final concentration of
100 mg/ml1 of gentamicin was added to the fresh medium. L. monocytogenes
was allowed to grow in the cells for 4 hr before bacteria and cells were
harvested from the plate and centrifuged at 13,000 rpm. Total RNAs were
extracted by use of the Fast RNA Pro Blue kit (Q-Biogen, MP Biomedicals,
Illkirch, France), following the manufacturer’s instructions. For qRT-PCR,
total RNAs were treated with 20 U of DNase I (Ambion) for 1 hr at 37C, and
concentrations were determined with Nanodrop (Nanodrop ND-1000
Spectrophotometer).
Complementation
For construction of sreA and sreB complemented strains, the corresponding
DNA fragment was amplified with PCR (oligonucleotides; sreA:#47 F and R
and sreB: #50 F and R) (Table S3) and was ligated at 16C overnight into
pGEM-T easy vector (Promega) system with T4 DNA ligase (Usb). JM109
high efficient competent cells (Promega) were transformed with pGEM-sreA
or pGEM-sreB, and the plasmid was thereafter recovered from overnight
cultured cells with QIAprep spin miniprep (QIAGEN). The pGEM construct
were digested with EcoR_ (Roche) and Sal_ (Roche), and the fragment was
purified with a gel extraction kit (QIAGEN) and was ligated with EcoR_ and
Sal_ digested pMK4 (19). JM109 cells were transformed with the pMK4
constructs, and transformants were spread on LB plates with carbenicillin
(50 mg/ml). Plasmids were harvested as previously and were transformed
into L. monocytogenes DsreA cells by electroporation (2.4 kV, 200 U, 25 mF)
and were spread on chloramphenicol plates (7 mg/ml). Sequence was verified
by using Dyenamic ET terminator kit.
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